India to Netherlands: Lisinopril Export Trade Route
India has recorded 34 verified shipments of Lisinopril exported to Netherlands, representing a combined trade value of $25.8M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $758.1K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 99% of total export value with 7 shipments worth $25.5M USD. On the buying side, MYLAN B,V, is the largest importer in Netherlands with $19.6M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Lisinopril corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $25.8M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's lisinopril manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $758.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.8%, placing it at rank #2 among India's top lisinopril export destinations globally.
On the import side, key buyers of Indian lisinopril in Netherlands include MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,, MYLAN B,V C/0 TJOAPACK, and 15 others. MYLAN B,V, is the single largest importer with 3 shipments valued at $19.6M USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#2
- Annual growth+30.8%
- Demand growth+27.6%
- Regulatory ease67/100
Top 10 Indian Lisinopril Exporters to Netherlands
Showing top 10 of 10 Indian suppliers exporting Lisinopril to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $3.6M per shipment | 7 | $25.5M | 98.8% |
| 2 | INTAS PHARMACEUTICALS LTD Avg $34.0K per shipment | 5 | $169.9K | 0.7% |
| 3 | MYLAN LABORATORIES LIMITED Avg $11.9K per shipment | 9 | $106.7K | 0.4% |
| 4 | AUROBINDO PHARMA LTD Avg $10.5K per shipment | 1 | $10.5K | 0.0% |
| 5 | S K age Exports Avg $3.3K per shipment | 2 | $6.6K | 0.0% |
| 6 | S K age Exports Avg $5.7K per shipment | 1 | $5.7K | 0.0% |
| 7 | ZKEE INTERNATIONAL Avg $1.0K per shipment | 4 | $4.2K | 0.0% |
| 8 | AUROBINDO PHARMA LIMITED Avg $1.6K per shipment | 2 | $3.1K | 0.0% |
| 9 | AUROBINDO PHARMA LTD Avg $1.4K per shipment | 1 | $1.4K | 0.0% |
| 10 | ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED Avg $46 per shipment | 2 | $91 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting lisinopril to Netherlands, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED , AUROBINDO PHARMA LTD, S K age Exports, S K age Exports , ZKEE INTERNATIONAL, AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA LTD , ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 7 shipments worth $25.5M USD, giving it a 99% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Lisinopril Importers in Netherlands
Showing top 10 of 18 known buyers in Netherlands receiving Lisinopril shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lisinopril in Netherlands include MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,, MYLAN B,V C/0 TJOAPACK,, ACCORD HEALTHCARE B V, M/S. MYLAN B.V C/O ALLOGA , among 18 total buyers. The largest importer is MYLAN B,V,, accounting for $19.6M USD across 3 shipments — representing 76% of all lisinopril imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN B,V, | 3 | $19.6M | 75.9% |
| 2 | MYLAN IRELAND C/O ALLOGA RDC, | 1 | $5.0M | 19.3% |
| 3 | MYLAN B,V C/0 TJOAPACK, | 1 | $898.1K | 3.5% |
| 4 | ACCORD HEALTHCARE B V | 5 | $169.9K | 0.7% |
| 5 | M/S. MYLAN B.V C/O ALLOGA | 2 | $39.1K | 0.2% |
| 6 | M/S. MYLAN IRELAND C/O ALLOGA RDC, | 4 | $37.9K | 0.1% |
| 7 | Mylan B.V., | 1 | $17.4K | 0.1% |
| 8 | MYLAN IRELAND C O ALLOGA RDC | 1 | $11.4K | 0.0% |
| 9 | AUROBINDO PHARMA B.V., | 1 | $10.5K | 0.0% |
| 10 | .MYLAN B.V.C/O ALLOGA | 1 | $8.9K | 0.0% |
Showing top 10 of 18 Lisinopril importers in Netherlands on this route.
Top 10 Lisinopril Formulations Imported by Netherlands
Showing top 10 of 29 product formulations shipped on the India to Netherlands Lisinopril route, ranked by trade value
Netherlands imports a wide range of lisinopril formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LISINOPRILMYLAN 2.5 MG 500BT TAB (PACKS 500S BOTTLE)(4791 PACKS X 500S=2395500 NOS) — accounts for $12.0M USD across 1 shipments. There are 29 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LISINOPRILMYLAN 2.5 MG 500BT TAB (PACKS 500S BOTTLE)(4791 PACKS X 500S=2395500 NOS) | 1 | $12.0M | 46.5% |
| 2 | LISINOPRIL 10 MG TABLETS 500BT (PACKS500S BOTTLE) (967 PACKS X 500S=483500NOS) | 1 | $5.0M | 19.3% |
| 3 | LISINOPRIL MYLAN 10 MG 500BT TAB (PACKS 500S BOTTLE) (948 PACKS X 500S=474000 NOS) | 1 | $4.7M | 18.3% |
| 4 | LISINOPRIL MYLAN 20 MG 500BT TAB (PACKS 500S BOTTLE) (476PACKS X 500S=238000NOS) | 1 | $2.9M | 11.1% |
| 5 | LISINOPRIL TABLETS BP 5 MG (PACKS 12000S BSP) | 1 | $898.1K | 3.5% |
| 6 | LISINOPRIL ACCORD 20 MG TAB | 2 | $100.6K | 0.4% |
| 7 | LISINOPRIL ACCORD 10 MG TAB | 3 | $69.3K | 0.3% |
| 8 | LISINOPRIL MYLAN 2.5 MG 500BT TAB PACKS | 1 | $30.4K | 0.1% |
| 9 | HARMLESS MEDICINES, LISINOPRIL MYLAN 2.5 | 1 | $17.4K | 0.1% |
| 10 | LISINOPRIL 20 MG TABLETS 500BT PACKS 951 | 1 | $11.6K | 0.0% |
Showing top 10 of 29 Lisinopril formulations imported by Netherlands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 6 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's lisinopril exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $758.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lisinopril 10 mg tablets 500bt (packs500s bottle) (967 packs x 500s=483500nos) and lisinopril mylan 10 mg 500bt tab (packs 500s bottle) (948 packs x 500s=474000 nos), suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN B,V, is the largest importer with 3 shipments worth $19.6M USD — representing 76% of all lisinopril imports from India on this route. A total of 18 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $25.8M
- Avg. Shipment
- $758.1K
- Suppliers
- 10
- Buyers
- 18
- Transit (Sea)
- ~23 days
- Annual Growth
- +30.8%
Related Analysis
Reverse Direction
Netherlands → India — Lisinopril (Import)Other Lisinopril Routes
Unlock the Full India to Netherlands Lisinopril Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 34 shipments on this route.
Frequently Asked Questions — India to Netherlands Lisinopril Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lisinopril to Netherlands?
The leading Indian exporters of Lisinopril to Netherlands are MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, MYLAN LABORATORIES LIMITED . MYLAN LABORATORIES LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Lisinopril exports from India to Netherlands?
India exports Lisinopril to Netherlands worth approximately $25.8M USD across 34 recorded shipments. The average value per shipment is $758.1K USD.
Q Which ports does India use to ship Lisinopril to Netherlands?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Netherlands for Lisinopril?
The average transit time for Lisinopril shipments from India to Netherlands is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Netherlands Lisinopril trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.8% with demand growth tracking at 27.6%. The route is ranked #2 among India's top Lisinopril export destinations globally.
Q How many suppliers are active on the India to Netherlands Lisinopril route?
There are currently 10 active Indian suppliers exporting Lisinopril to Netherlands. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Lisinopril from India in Netherlands?
The leading importers of Indian Lisinopril in Netherlands include MYLAN B,V,, MYLAN IRELAND C/O ALLOGA RDC,, MYLAN B,V C/0 TJOAPACK,, ACCORD HEALTHCARE B V, M/S. MYLAN B.V C/O ALLOGA . MYLAN B,V, is the largest buyer with 3 shipments worth $19.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Lisinopril.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 18 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 34 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
34 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists